Showing 1831-1840 of 2748 results for "".
- ISHRS Survey: Surgical Advances; Improvements in Efficiency Driving Need for Fewer Hair Transplant Treatmentshttps://modernaesthetics.com/news/ishrs-survey-surgical-advances-improvements-in-efficiency-driving-need-for-fewer-hair-transplant-treatments/2473235/According to results of a new member survey conducted by the International Society of Hair Restoration Surgery (ISHRS), 68 percent of members reported performing an average of one procedure per patient in 2021 to achieve the desired hair restoration result. This represents a significant improveme
- Meet Avéli, Cellulite's Latest Foehttps://modernaesthetics.com/news/meet-aveli-cellulites-latest-foe/2473234/Revelle Aesthetics, In
- CellFX from Pulse Biosciences Shows Durable Effects for Sebaceous Hyperplasia: ASLMS Presentationhttps://modernaesthetics.com/news/cellfx-from-pulse-biosciences-shows-durable-effects-for-sebaceous-hyperplasia-aslms-presentation/2473233/The CellFX® system from Pulse Biosciences, Inc. demonstrates durable efficacy for the clearance of Sebaceous Hyperplasia lesions, according to data presented at the 2022
- ASERF Names New Executive Committee Membershttps://modernaesthetics.com/news/aserf-names-new-executive-committee-members/2473232/Indianapolis plastic surgeon Bruce Van Natta, MD is the new President of The Aesthetic Surg
- Dr. Jennifer Walden Named President of the Aesthetic Societyhttps://modernaesthetics.com/news/dr-jennifer-walden-named-president-of-the-aesthetic-society/2473231/Austin, TX-based Jennifer Walden, MD is the first female Aesthetic Society President. "I am looking forward to serving The Aesthetic Society as its first female president. Born in 1971, I believe it was Title IX1 that set the stage for me as a young girl. I was
- Coming This Week: Cutera AviClear Webinarhttps://modernaesthetics.com/news/coming-this-week-cutera-aviclear-webinar/2473230/Cutera hosts the first webinar for AviClear, the first and only FDA cleared energy-based device for the treatment of mild, moderate, and severe acne, this week. Dermatologists Jeffrey S. Dover, MD, FRCPC and Julie C. Harper, MD will discuss the latest advancement in the treatment of acn
- Colorescience, Aesthetics Biomedical Join Forces for New Collabhttps://modernaesthetics.com/news/colorescience-aesthetics-biomedical-join-forces-for-new-collab/2473229/Colorescience and Aesthetics Biomedical are launching a collaboration that combines Vivace Microneedle RF with a post-treatment protocol featuring Colorescience’s Sunforgettable Total Protection Brush-On Shield SPF 50. Patients opting for the radiofrequency microneedlin
- Elevai Labs Names Chief Marketing and Brand Advisorhttps://modernaesthetics.com/news/elevai-labs-names-chief-marketing-and-brand-advisor/2473228/Brenda Buechler is now Chief Marketing and Brand Advisor for Elevai Labs, Inc. Elevai is a science-based aesthetic skincare company providing topical formulations featuring by ethically sourced, human umbilical mesenchymal stem cells (hUMSC)-derived e
- New from Lumenis: triLift Targets Three Elements of Aginghttps://modernaesthetics.com/news/new-form-lumenis-trilift-targets-three-elements-of-aging/2473227/Lumenis Be, Ltd., has launched triLift, a facial stimulation device targeting three aging elements—structure, contour, and texture—by treating the three tissue layers. The device affects the muscl
- Revance News: FDA Accepts BLA Resubmission for DaxibotulinumtoxinAhttps://modernaesthetics.com/news/revance-news-fda-accepts-bla-resubmission-for-daxibotulinumtoxina/2473223/The U.S. Food and Drug Administration (FDA) accepted Revance’s Biologics License Application (BLA) resubmission for DaxibotulinumtoxinA for Injection for the treatment of moderate to severe glabellar lines. The FDA designated the BLA as a Class 2 resubmission, which has a six-mont